We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+2.37%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.8B
AUM Growth
+$988M
(+10%)
Cap. Flow
+$812M
Cap. Flow
% of AUM
7.54%
Top 10 Holdings %
Top 10 Hldgs %
14.36%
Holding
2,596
New
200
Increased
685
Reduced
635
Closed
273
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$32.7M |
| 2 |
Eli Lilly
LLY
|
+$31M |
| 3 |
La-Z-Boy
LZB
|
+$17.4M |
| 4 |
Ubiquiti
UI
|
+$17.1M |
| 5 |
TriMas Corp
TRS
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LSB Industries
LXU
|
+$14M |
| 2 |
K
Kellanova
K
|
+$13.7M |
| 3 |
Apple
AAPL
|
+$13.1M |
| 4 |
Prosperity Bancshares
PB
|
+$11.7M |
| 5 |
Fluor
FLR
|
+$11.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.72% |
| 2 | Industrials | 12.7% |
| 3 | Healthcare | 12.22% |
| 4 | Financials | 10.93% |
| 5 | Energy | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FNSR
151
DELISTED
Finisar Corp
FNSR
| $17.9M | 0.17% |
674,526
+108,473
| +19% | +$2.6M |
|
152
Matrix Service
MTRX
$347M
| $17.8M | 0.16% |
526,158
+116,694
| +28% | +$3.49M |
|
|
153
La-Z-Boy
LZB
$1.59B
| $17.7M | 0.16% |
653,012
+635,101
| +3,546% | +$17.4M |
|
154
Steven Madden
SHOO
$3.12B
| $17.6M | 0.16% |
735,824
+148,484
| +25% | +$3.44M |
|
155
Grand Canyon Education
LOPE
$3.71B
| $17.5M | 0.16% |
375,386
+111,629
| +42% | +$5.17M |
|
156
Texas Roadhouse
TXRH
$12.7B
| $17.5M | 0.16% |
669,652
+111,635
| +20% | +$2.88M |
|
157
iShares MSCI ACWI ex US ETF
ACWX
$11.3B
| $17.4M | 0.16% |
373,294
-116,101
| -24% | -$5.28M |
|
158
Moog Inc Class A
MOG.A
$13B
| $17.2M | 0.16% |
262,943
+42,737
| +19% | +$2.71M |
|
159
Novartis
NVS
$295B
| $17.2M | 0.16% |
225,145
-47,763
| -18% | -$3.48M |
|
160
Vanguard S&P 500 ETF
VOO
$968B
| $17.1M | 0.16% |
100,093
+36,748
| +58% | +$6.18M |
|
161
Boise Cascade
BCC
$2.74B
| $17.1M | 0.16% |
598,686
+379,338
| +173% | +$11.2M |
|
162
Crane NXT
CXT
$3.04B
| $17.1M | 0.16% |
693,614
+115,681
| +20% | +$2.73M |
|
163
Wabash National
WNC
$543M
| $17M | 0.16% |
1,237,467
+206,985
| +20% | +$2.77M |
|
164
Blackrock
BLK
$164B
| $16.9M | 0.16% |
53,668
-29,142
| -35% | -$8.91M |
|
165
Danaher
DHR
$135B
| $16.9M | 0.16% |
334,511
+26,772
| +9% | +$1.36M |
|
|
NVO
166
Novo Nordisk
NVO
$216B
| $16.8M | 0.16% |
737,260
+8,050
| +1% | +$172K |
|
167
Cinemark Holdings
CNK
$3.82B
| $16.8M | 0.16% |
577,894
+95,950
| +20% | +$2.88M |
|
|
BDN
168
Brandywine Realty Trust
BDN
$551M
| $16.7M | 0.16% |
1,156,057
+303,921
| +36% | +$4.33M |
|
|
CHSP
169
DELISTED
Chesapeake Lodging Trust
CHSP
| $16.7M | 0.15% |
648,611
+20,406
| +3% | +$517K |
|
|
HNGR
170
DELISTED
Hanger Inc.
HNGR
| $16.7M | 0.15% |
494,716
+72,343
| +17% | +$2.62M |
|
|
WDR
171
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $16.6M | 0.15% |
226,111
+19,557
| +9% | +$1.34M |
|
172
Gartner
IT
$9.41B
| $16.6M | 0.15% |
239,601
-2,011
| -0.8% | -$139K |
|
|
173
Ubiquiti
UI
$31.8B
| $16.6M | 0.15% |
365,574
+365,458
| +315,050% | +$17.1M |
|
|
VAR
174
DELISTED
Varian Medical Systems, Inc.
VAR
| $16.6M | 0.15% |
224,929
-144,161
| -39% | -$10.4M |
|
|
ALR
175
DELISTED
Alere Inc
ALR
| $16.5M | 0.15% |
480,427
+78,069
| +19% | +$2.85M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2014 Portfolio in Review
As of Q1 2014, Glenmede Trust held 2,596 positions worth $10.8B, up 10% from $9.79B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Glenmede Trust deployed $812M of net new capital in Q1 2014, opening 200 new positions and adding to 685 existing holdings. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Kellanova, an estimated $13.7M trimmed.
- Glenmede Trust's largest Q1 2014 buy was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.
- Glenmede Trust added most to Eli Lilly in Q1 2014, an estimated $31M increase.
- Glenmede Trust's biggest Q1 2014 reduction was Kellanova, cutting an estimated $13.7M.
- Glenmede Trust fully exited LSB Industries in Q1 2014, selling an estimated $14M.
- Glenmede Trust's ten largest holdings make up 14% of its $10.8B portfolio in Q1 2014.
- Glenmede Trust opened 200 new positions and closed 273 in Q1 2014.
- Glenmede Trust's portfolio value rose 10% quarter-over-quarter to $10.8B.
Based on Glenmede Trust's 13F filing for Q1 2014, filed 7 May 2014.